MOTS-c 40mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of MOTS-C supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF112025074

Key analytical results include:

• Assay Content: 45.6 mg
• Identification – Retention Time: 0.996
• Identification – Spectrum: 1000
• Purity: greater than 99.6 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

MOTS-C is a mitochondrial-derived peptide research compound frequently studied in controlled laboratory environments focused on cellular metabolic regulation and mitochondrial signalling pathways.

The compound belongs to a class of short peptides encoded within mitochondrial DNA that are investigated for their role in intracellular energy regulation and metabolic signalling systems.

This preparation contains 40 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, MOTS-C has become a compound referenced in experimental mitochondrial signalling and metabolic regulation research models.

Compound Overview

MOTS-C is a mitochondrial-derived peptide encoded within the mitochondrial genome and studied in biochemical research examining mitochondrial signalling and metabolic regulation.

The peptide has attracted scientific interest due to its interaction with pathways involved in cellular energy balance and metabolic signalling.

Within experimental laboratory systems, MOTS-C is often examined in models studying mitochondrial communication with nuclear signalling networks and intracellular metabolic control mechanisms.

These experimental systems allow scientists to investigate mitochondrial peptide signalling and its potential influence on cellular metabolic pathways.

Historical Background and Scientific Context

Scientific research into mitochondrial signalling expanded significantly during the early twenty-first century as new mitochondrial-derived peptides were discovered.

Researchers studying mitochondrial DNA identified several short peptides encoded within the mitochondrial genome that appear to participate in cellular regulatory processes.

MOTS-C was identified as one of these mitochondrial-derived peptides and subsequently became a subject of experimental biochemical research exploring mitochondrial-to-nuclear signalling pathways.

Since its discovery, the peptide has been studied in various experimental models investigating metabolic signalling, mitochondrial communication and intracellular regulatory mechanisms.

Mechanistic Focus in Research

Within experimental laboratory environments, MOTS-C is commonly studied in relation to mitochondrial signalling pathways and cellular metabolic regulation.

Research investigations frequently explore the compound in experimental models examining:

• Mitochondrial signalling pathways
• Cellular metabolic regulation networks
• Mitochondrial-nuclear communication mechanisms
• Intracellular energy regulation pathways
• Metabolic signalling research models
• Comparative mitochondrial peptide studies
• Cellular metabolic response systems

These experimental models allow scientists to investigate molecular signalling mechanisms involved in mitochondrial peptide regulation.

Research Applications

In controlled research environments, MOTS-C may be utilised in experimental models designed to explore mitochondrial signalling systems and metabolic regulatory pathways.

Examples of research applications include:

• Mitochondrial signalling pathway investigation
• Metabolic pathway research
• Cell signalling analysis
• Mitochondrial-derived peptide research
• Comparative metabolic compound evaluation
• Intracellular regulatory network modelling
• Controlled in vitro metabolic studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

Verified and analysed with Liquilabs s.r.o. (Czechia)
High-purity mitochondrial research peptide
Validated assay content 45.6 mg with 99.6% purity
Retention time and spectral identification confirmed
Endotoxin levels below 0.001 EU per mg
No detectable heavy metals or microbial growth
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.